PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-20.50%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
7.33%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
-37.39%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-21.25%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
23.91%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
-59.26%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
20.68%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
13.52%
Total costs growth while VET reduces costs. John Neff would investigate differences.
27.85%
Interest expense growth while VET reduces costs. John Neff would investigate differences.
8.81%
D&A growth while VET reduces D&A. John Neff would investigate differences.
60.69%
EBITDA growth while VET declines. John Neff would investigate advantages.
-213.10%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-101.25%
Both companies show declining income. Martin Whitman would check industry conditions.
-101.57%
Both companies show margin pressure. Martin Whitman would check industry conditions.
8666.67%
Other expenses growth above 1.5x VET's 46.63%. Michael Burry would check for concerning trends.
59.63%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
100.79%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
5800.00%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
-11.18%
Both companies show declining income. Martin Whitman would check industry conditions.
11.72%
Net margin growth while VET declines. John Neff would investigate advantages.
-11.76%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-11.76%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
0.01%
Share count reduction exceeding 1.5x VET's 0.64%. David Dodd would verify capital allocation.
0.01%
Diluted share increase while VET reduces shares. John Neff would investigate differences.